HHIP

HHIP (Hedgehog-Interacting Protein) is a vertebrate-specific, cell-surface antagonist of Hedgehog (Hh) signaling that restrains Hh pathway activity during development, tissue homeostasis, and disease. Its ectodomain, composed of two EGF domains and a six-bladed β-propeller, functions as a structural decoy receptor: a critical loop from the propeller directly coordinates the Zn²⁺ ion in the pseudo-active-site groove of Hh ligands (SHH, DHH), competitively blocking Patched binding, with Ca²⁺ modulating complex affinity by preventing electrostatic repulsion (PMID:19561609, PMID:19561611). Beyond ligand sequestration, HHIP co-localizes with Smoothened at the cell surface and co-internalizes with it upon Hh stimulation, providing a second, membrane-anchoring-dependent mechanism for attenuating signaling (PMID:16765934). HHIP expression is epigenetically silenced by promoter CpG-island hypermethylation in cancers such as pancreatic cancer and hepatocellular carcinoma (PMID:15970691, PMID:31604528), and is reduced in COPD lungs through COPD-risk SNPs in a distal enhancer that increase Sp3-mediated transcriptional repression (PMID:22140090).

1. 2005 High

   Establishing that HHIP is epigenetically silenced in cancer answered whether loss of this Hh antagonist could be a tumor-relevant event: promoter CpG hypermethylation abolishes HHIP expression in pancreatic cancer, and demethylation restores it and reduces Gli activity.

   Evidence Bisulfite sequencing, methylation-specific PCR, Gli luciferase reporter, 5-aza-dC treatment in pancreatic cancer lines and primary tumors

   PMID:15970691

   Open questions at the time

   • Whether HHIP re-expression suppresses tumor growth in vivo was not tested
   • Mechanism linking methylation to tumorigenesis not fully delineated
2. 2006 High

   Demonstrating that HHIP antagonizes Hh not only by sequestering ligand but also by co-internalizing with Smoothened revealed a dual-mechanism model for HHIP function at the cell surface, explaining why membrane-anchored HHIP is more effective than a secreted form.

   Evidence Live imaging, morpholino knockdown, domain-deletion constructs, and muscle marker analysis in zebrafish

   PMID:16765934

   Open questions at the time

   • Biochemical basis of HHIP–Smoothened interaction not defined
   • Whether this co-internalization mechanism operates in mammals remains untested
3. 2009 High

   Crystal structures of HHIP bound to SHH and DHH resolved the atomic mechanism of ligand antagonism: the β-propeller loop coordinates the Hh Zn²⁺ ion in its pseudo-active-site groove, acting as a decoy receptor, while Ca²⁺ modulates binding affinity.

   Evidence X-ray crystallography of HHIP–SHH and HHIP–DHH complexes ± Ca²⁺, site-directed mutagenesis, binding assays (two independent groups)

   PMID:19561609 PMID:19561611

   Open questions at the time

   • No structure with IHH
   • Contribution of the EGF domains to in vivo function unclear
   • Dynamics of the interaction in a membrane context not addressed
4. 2011 High

   Identifying a distal enhancer ~85 kb upstream that loops to the HHIP promoter, and showing that COPD-risk SNPs increase Sp3 repressor binding to reduce HHIP transcription, established the regulatory mechanism linking common genetic variants to HHIP downregulation in COPD.

   Evidence Chromatin conformation capture, luciferase reporter assays, EMSA for Sp3 binding, qRT-PCR in COPD lung tissues

   PMID:22140090

   Open questions at the time

   • Whether Sp3-mediated repression is sufficient to explain COPD pathology
   • No CRISPR-based allele editing to confirm causality of individual SNPs
5. 2019 Medium

   Discovery that the antisense lncRNA HHIP-AS1 stabilizes HHIP mRNA in a HuR-dependent manner revealed a post-transcriptional regulatory layer controlling HHIP abundance and, consequently, Hh signaling output in hepatocellular carcinoma.

   Evidence RNA immunoprecipitation, lncRNA overexpression/knockdown, HuR-dependency assays, proliferation and migration assays in HCC cells

   PMID:31604528

   Open questions at the time

   • Single-lab finding without independent replication
   • In vivo relevance of HHIP-AS1 regulation not demonstrated
6. 2021 High

   Showing that Hhip-expressing mesenchymal cells maintain coronal suture patency by restraining Hh signaling—and that Hhip knockout leads to suture depletion—established HHIP as a critical regulator of cranial suture fate.

   Evidence Single-cell RNA-seq, genetic lineage tracing, Hhip-/- mouse histology and Hh signaling readouts

   PMID:34880220

   Open questions at the time

   • Whether HHIP mutations cause craniosynostosis in humans is unknown
   • Downstream transcriptional targets in suture mesenchyme not identified
7. 2021 Medium

   Demonstrating that HHIP haploinsufficiency increases aerobic glycolysis and airway smooth muscle mass linked Hh pathway de-repression to metabolic reprogramming in COPD pathogenesis.

   Evidence Metabolic flux assays, HHIP knockdown/overexpression in primary ASMCs, Hhip+/- mouse with cigarette smoke exposure

   PMID:33907231

   Open questions at the time

   • Whether PKM2 is a direct or indirect target of HHIP-regulated signaling
   • Single-lab finding; metabolic mechanism needs independent confirmation

• The biochemical basis of HHIP–Smoothened co-internalization, whether HHIP directly contacts Smoothened, and the identity of additional downstream effectors beyond canonical Gli signaling remain unresolved.
• No structural or biochemical characterization of HHIP–Smoothened interaction
• No systematic identification of HHIP-dependent transcriptional programs across tissues
• Role of HHIP in non-canonical Hh signaling unexplored